APA

Adam Z., Matýková M., Krejcí M., Pour L., Kissová J., Slechtová M., Chlupová G., Stavarová Y., Simonides J., Penka M., Mayer J. & Hájek R. (20100316). [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]. : Vnitrni lekarstvi.

Chicago

Adam Z, Matýková M, Krejcí M, Pour L, Kissová J, Slechtová M, Chlupová G, Stavarová Y, Simonides J, Penka M, Mayer J and Hájek R. 20100316. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]. : Vnitrni lekarstvi.

Harvard

Adam Z., Matýková M., Krejcí M., Pour L., Kissová J., Slechtová M., Chlupová G., Stavarová Y., Simonides J., Penka M., Mayer J. and Hájek R. (20100316). [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]. : Vnitrni lekarstvi.

MLA

Adam Z, Matýková M, Krejcí M, Pour L, Kissová J, Slechtová M, Chlupová G, Stavarová Y, Simonides J, Penka M, Mayer J and Hájek R. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]. : Vnitrni lekarstvi. 20100316.